19-35030820-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001037.5(SCN1B):c.-1C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000185 in 1,082,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000011 ( 0 hom. )
Consequence
SCN1B
NM_001037.5 5_prime_UTR
NM_001037.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.175
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN1B | NM_001037.5 | c.-1C>T | 5_prime_UTR_variant | 1/6 | ENST00000262631.11 | NP_001028.1 | ||
SCN1B | NM_199037.5 | c.-1C>T | 5_prime_UTR_variant | 1/3 | NP_950238.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1B | ENST00000262631.11 | c.-1C>T | 5_prime_UTR_variant | 1/6 | 1 | NM_001037.5 | ENSP00000262631 | P1 | ||
SCN1B | ENST00000415950.5 | c.-1C>T | 5_prime_UTR_variant | 1/3 | 1 | ENSP00000396915 | ||||
SCN1B | ENST00000638536.1 | c.-1C>T | 5_prime_UTR_variant | 1/5 | 1 | ENSP00000492022 | P1 | |||
SCN1B | ENST00000595652.5 | c.-1C>T | 5_prime_UTR_variant | 1/6 | 2 | ENSP00000468848 |
Frequencies
GnomAD3 genomes AF: 0.00000670 AC: 1AN: 149184Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
149184
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000107 AC: 1AN: 933330Hom.: 0 Cov.: 13 AF XY: 0.00000219 AC XY: 1AN XY: 456526
GnomAD4 exome
AF:
AC:
1
AN:
933330
Hom.:
Cov.:
13
AF XY:
AC XY:
1
AN XY:
456526
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000670 AC: 1AN: 149184Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72742
GnomAD4 genome
AF:
AC:
1
AN:
149184
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
72742
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 05, 2016 | A variant of uncertain significance has been identified in the SCN1B gene. The c.-1 C>T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. Although the c.-1 C>T variant was not observed in approximately 1,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, the data was noted to have reduced depth of sequencing reads and therefore may be unreliable. It occurs at a position that is conserved in mammals. This substitution alters a position in the Kozak sequence, which is located in the 5' untranslated region (UTR) of the gene and plays a role in the initiation of protein translation. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Additionally, variants in the 5' UTR of the SCN1B gene have not been reported in the Human Gene Mutation Database (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.-1C>T variant is located in the 5' untranslated region (5’ UTR) of the SCN1B gene. This variant results from a C to T substitution 1 nucleotide upstream from the first translated codon. This nucleotide position is highly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at